Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT04238221
PHASE4

Effect of add-on Doxofylline on Lung Function in Stable COPD

Sponsor: University of Milan

View on ClinicalTrials.gov

Summary

It is a phase IV, prospective, interventional, single blind, randomized, crossover trial in which the investigators will evaluate the effects of a 4-week treatment with doxofylline 400 mg bid, in add-on to maximal inhalation therapy, in clinically stable COPD patients.

Official title: Effect of Doxofylline on Bronchial Obstruction, in add-on to Maximal Inhalation Therapy, in Clinically Stable COPD Patients.

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

78

Start Date

2026-12-01

Completion Date

2027-12-30

Last Updated

2026-04-29

Healthy Volunteers

No

Interventions

DRUG

Doxofylline

Patients will receive a 4-week treatment with doxofylline 400 mg bid, in addition to their chronic usual inhalation therapy.

Locations (1)

L. Sacco Hospital

Milan, Italy